02:28

Support Peer's Cykelnerven ride for MS

05:37

The Progressive MS Alliance 2024 Progress Report

34:41

Professor Klaus Schmierer on Cladribine use in MS

26:54

MSIF's webpage and resources on access to MS Healthcare

31:27

Key steps to get started in using the WHO EML in your advocacy efforts

13:20

WHO EML associated case study from the MS movement - Malaysia

12:58

The impact of WHO EML listing on access to MS DMTs

13:01

WHO EML associated case study from the MS movement - New Zealand

03:42

A video message from Peer Baneke announcing the WHO's decision

03:06

Sharifah's story - Malaysia

02:51

Tarrbinder's story - Malaysia

01:20

Abdelhakim's story - Morocco

02:25

Oumaima's story - Morocco

02:50

Dr Shanthi Viswanathan - Malaysia

01:31

Professor Belahsen - Morocco

21:08

National access to DMTs in India

12:03

Access to DMTs in Serbia

12:55

Access to DMTs in Thailand

14:25

National Essential Medicine List in Malaysia

03:16

Cykelnerven 2023 - Day Four

02:17

Cykelnerven 2023 - Day Three

02:10

Cykelnerven 2023 - Day Two

02:21

Cykelnerven 2023 - Day One

05:28

Cykelnerven - Chris Ramsey Interview

00:16

Cykelnerven - Route Trailer #2

01:25

Cykelnerven - Thomas Riedel Interview

01:03

Cykelnerven - Tomas' Story

01:14

Progressive MS Alliance Announces New Global Research Initiative on Well-Being #shorts

31:54

MSIF application to the World Health Organization Essential Medicine List - Nick Rijke

34:02

Developing treatments to end MS progression: Recent advances and promising research

03:30

Cykelnerven Legends - David Sharrock Interview

02:55

Cykelnerven - Route Trailer #1

05:03

Collaborative network led by Francisco Quintana, Ph.D. - International Progressive MS Alliance

01:06

Globalne twarze SM - ludzie stojący za liczbami (polski)

02:59

Atlas da EM - barreiras ao diagnóstico, tratamento e cuidados (português)

13:41

الجزء 1 : أطلس التصلّب العصبي المُتعدّد وكيف يمكن الاستعانة به في المناصرة

31:13

Example of the power of data from India (The power of data webinar part 2)

34:18

الجزء 3: مثال على قوة البيانات التي تم جمعها من إسبانيا

33:23

الجزء 2: مثال على قوة البيانات التي تم جمعها من الهند

30:48

Ejemplo del poder de los datos provenientes de la España pt.3

30:44

Ejemplo del poder de los datos provenientes de la India pt.2

13:42

El Atlas de la Esclerosis Múltiple y cómo se puede utilizar para incidir en políticas públicas pt.1

13:43

The Atlas of MS and how it can be used in advocacy (The Power of Data webinar part 1)

31:12

Example of the power of data from Spain (The Power of Data part 3)

42:13

Solving the mystery of progression: the key to new treatments for progressive MS

53:56

MSIF Off-label Treatments presentation and Q&A (PACTRIMS, June 2022)

01:50

Die COVID-19- und MS-Initiative zum globalen Datenaustausch sagt Danke!

01:50

المبادرة العالمية لمشاركة البيانات حول جائحة كوفيد-19 والتصلّب العصبي المُتعدّد - شكرًا لكم.

01:50

The COVID-19 and MS global data sharing initiative – thank you!

01:50

Iniciativa mundial de datos de EM y COVID-19 – ¡Gracias!

22:00

Joanna Laurson-Doube on ethical use of off-label DMTs in MS

29:32

Access to treatment in Egypt - Dr Mai Sharway and Prof Magd Zakaria

03:38

Atlas for Change - MS Ireland case study (Arabic)

08:55

Atlas for Change - MS Society of India case study (Arabic)

04:14

Atlas for Change - Danish MS Society case study (Arabic)

04:16

Atlas for Change - Danish MS Society case study (Spanish)

08:55

Atlas for Change - MS Society of India case study (Spanish)

03:26

Atlas for Change - MS Ireland case study (Spanish)

08:51

Atlas for Change - MS Society of India case study (English)

03:21

Atlas for Change - MS Ireland case study (English)